A Statement from our Co-Founders and Co-CEOs Glen de Vries and Tarek Sherif
Acorn AI is designed to make data liquid across the lifecycle and answer the most important questions.
The Impact of COVID-19 on Clinical Trial Sites
Medidata surveyed over 1,000 sites to see how the COVID-19 pandemic is affecting their ability to start, conduct and complete clinical studies.
COVID-19 and Clinical Trials: The Medidata Perspective
As the global impact of COVID-19 increases, Medidata is continuously analyzing its effect on patient study enrollment, the response by world regulatory bodies and which Medidata’s solutions can help address your COVID 19-related challenges.
[SCOPE Webinar] How Five COVID-19 Technology Innovations are Reducing Risk in Clinical Trials
Join our next panel discussion—including live Q&A—exploring how regulators and sponsors have reimagined technology innovations addressing the impact of COVID-19.